MedPath

ICOS Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 3
1 (33.3%)

Interstitial Cystitis

Phase 2
Completed
Conditions
Interstitial Cystitis
First Posted Date
2003-03-10
Last Posted Date
2005-06-24
Lead Sponsor
ICOS Corporation
Target Recruit Count
150
Registration Number
NCT00056251
Locations
🇺🇸

Alaska Clinical Research Center, Anchorage, Alaska, United States

🇺🇸

Citrus Valley Medical Research, Inc., Glendora, California, United States

🇺🇸

Center for Urological Research, La Mesa, California, United States

and more 21 locations

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Phase 2
Completed
Conditions
Pneumonia
Sepsis
First Posted Date
2002-08-05
Last Posted Date
2005-06-24
Lead Sponsor
ICOS Corporation
Registration Number
NCT00042588
Locations
🇺🇸

ICOS Corporation, Bothell, Washington, United States

Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis

Phase 3
Terminated
Conditions
Sepsis
First Posted Date
2002-05-21
Last Posted Date
2005-06-24
Lead Sponsor
ICOS Corporation
Target Recruit Count
2500
Registration Number
NCT00037687
Locations
🇺🇸

Mary E. Lonien, M.S., Bothell, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.